offerings – Talk Bio

Actionable Insights Powered by AI

Upstream Biotech Prepares to Join the Wave of Biotech IPOs with Inflammation-Focused Therapies

7 months ago talkbio0Tagged biotech, Biotechnology, healthcare innovation, Industry, Inflammation-Focused Therapies, IPOs, offerings, public entity, Upstream

Biotech IPOs, Upstream Biotech, Inflammation-focused therapies, Biotechnology industry, Public offerings, Healthcare innovation

Telix Pharmaceuticals Aims for $200 Million IPO in Radiopharmaceuticals Market Amid Slowing Biotech Nasdaq Offerings

11 months ago talkbio0Tagged biotech, IPO, Nasdaq, offerings, Radiopharmaceuticals, Telix

Telix Pharmaceuticals, Radiopharmaceuticals, IPO, Biotech, Nasdaq Offerings